Cargando…

The Prognostic Value of B‐Type Natriuretic Peptide in Patients With Cardiac Sarcoidosis Without Heart Failure: Insights From ILLUMINATE‐CS

BACKGROUND: The prognostic role of BNP (B‐type natriuretic peptide) in patients with cardiac sarcoidosis without evident heart failure is unknown. METHODS AND RESULTS: This is a post hoc analysis of ILLUMINATE‐CS (Illustration of the Management and Prognosis of Japanese Patients With Cardiac Sarcoid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyakuni, Shota, Maeda, Daichi, Matsue, Yuya, Yoshioka, Kenji, Dotare, Taishi, Sunayama, Tsutomu, Nabeta, Takeru, Naruse, Yoshihisa, Kitai, Takeshi, Taniguchi, Tatsunori, Tanaka, Hidekazu, Okumura, Takahiro, Baba, Yuichi, Matsumura, Akihiko, Minamino, Tohru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798822/ https://www.ncbi.nlm.nih.gov/pubmed/36515231 http://dx.doi.org/10.1161/JAHA.122.025803

Ejemplares similares

Prevalence and prognostic value of atrial fibrillation in patients with cardiac sarcoidosis
por: Fujimoto, Yudai, et al.
Publicado: (2023)

Prognostic Implication of the Resolution of Myocardial FDG Uptake in Patients With Cardiac Sarcoidosis
por: Okabe, Toshitaka, et al.
Publicado: (2023)

Effectiveness of methotrexate as a second-line treatment for cardiac sarcoidosis assessed via (18)F-FDG PET: a case report
por: Dotare, Taishi, et al.
Publicado: (2022)

Urinary liver‐type fatty acid‐binding protein as a prognostic marker in patients with acute heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Impact of brain natriuretic peptide reduction on the worsening renal function in patients with acute heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2020)

Prognostic value of postural hypotension in hospitalized patients with heart failure
por: Sunayama, Tsutomu, et al.
Publicado: (2022)

Inaccurate recognition of own comorbidities is associated with poor prognosis in elderly patients with heart failure
por: Maeda, Daichi, et al.
Publicado: (2022)

Sarcopenic obesity is associated with impaired physical function and mortality in older patients with heart failure: insight from FRAGILE-HF
por: Saito, Hiroshi, et al.
Publicado: (2022)

Association between class of foundational medication for heart failure and prognosis in heart failure with reduced/mildly reduced ejection fraction
por: Ito, Miyuki, et al.
Publicado: (2022)

Aspartate aminotransferase to alanine aminotransferase ratio is associated with frailty and mortality in older patients with heart failure
por: Maeda, Daichi, et al.
Publicado: (2021)

Kaplan–Meier survival analysis and Cox regression analyses regarding right ventricular septal pacing: Data from Japanese pacemaker cohort
por: Mizukami, Akira, et al.
Publicado: (2016)

Clinical implication of initial intravenous diuretic dose for acute decompensated heart failure
por: Yoshioka, Kenji, et al.
Publicado: (2022)

Inflammatory and Hypercoagulable Biomarkers and Clinical Outcomes in COVID-19 Patients
por: Kitakata, Hiroki, et al.
Publicado: (2021)

Clinical valuables related to resolution of complete or advanced atrioventricular block after steroid therapy in patients with cardiac sarcoidosis
por: Nabeta, Takeru, et al.
Publicado: (2021)

Real-Life Utilization of Criteria Guidelines for Diagnosis of Cardiac Sarcoidosis (CS)
por: Gazitt, Tal, et al.
Publicado: (2023)

Impact of body mass index on the outcome of Japanese patients with cardiovascular diseases and/or risk factors hospitalized with COVID-19 infection
por: Saito, Takafumi, et al.
Publicado: (2022)

Sex Differences in Clinical Outcomes Among Patients With COVID-19 and Cardiovascular Disease　― Insights From the CLAVIS-COVID Registry ―
por: Matsumoto, Shingo, et al.
Publicado: (2022)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
por: Miyoshi, Takekazu, et al.
Publicado: (2021)

Effect of the COVID-19 Pandemic on Acute Respiratory Care of Hypoxemic Patients With Acute Heart Failure in Japan　― A Cross-Sectional Study ―
por: Matsue, Yuya, et al.
Publicado: (2020)

Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors
por: Higaki, Akinori, et al.
Publicado: (2022)

External validation of the 4C Mortality Score for patients with COVID-19 and pre-existing cardiovascular diseases/risk factors
por: Kuroda, Shunsuke, et al.
Publicado: (2021)

Histological examination of the right atrial appendage after failed catheter ablation for focal atrial tachycardia complicated by cardiogenic shock in a post-partum patient
por: Mizukami, Akira, et al.
Publicado: (2016)

Hepatocellular carcinoma associated with sarcoidosis
por: Arai, Takuma, et al.
Publicado: (2014)

9‐Year Trend in the Management of Acute Heart Failure in Japan: A Report From the National Consortium of Acute Heart Failure Registries
por: Shiraishi, Yasuyuki, et al.
Publicado: (2018)

Tolvaptan Add-on Therapy to Overcome Loop Diuretic Resistance in Acute Heart Failure With Renal Dysfunction (DR-AHF): Design and Rationale
por: Minh, Nhat Giang, et al.
Publicado: (2022)

Response to letter to the editor entitled “Association between left atrial sphericity index and clinical outcomes in patients with systolic heart failure”
por: Yazaki, Mayu, et al.
Publicado: (2021)

Sarcoidosis Illuminations on Living During COVID-19: Patient Experiences of Diagnosis, Management, and Survival Before and During the Pandemic *
por: Saketkoo, Lesley Ann, et al.
Publicado: (2022)

Superiority of proatrial natriuretic peptide in the prognostic power in patients with acute decompensated heart failure on hospital admission: comparison with B-type natriuretic peptide and other natriuretic peptide forms
por: Takashio, Seiji, et al.
Publicado: (2019)

Validation of telemedicine-based self-assessment of vital signs for patients with COVID-19: A pilot study
por: Kagiyama, Nobuyuki, et al.
Publicado: (2021)

Assessment of thromboembolism risk in COVID-19 patients with cardiovascular disease risk factors: Analysis of a Japanese Nationwide Registry()
por: Shibahashi, Eiji, et al.
Publicado: (2022)

An Irreversible Worsening Cardiac Function after Withdrawing Medical Treatments in a Patient with Dilated Cardiomyopathy: A Pathological Analysis
por: Yazaki, Mayu, et al.
Publicado: (2020)

N-terminal pro-b-type natriuretic peptide (nt-pro-bnp) as outcome predictor after cardiac surgery (CS)
por: Pavalascu, A, et al.
Publicado: (2015)

Endomyocardial Biopsy for the Diagnosis of Transthyretin Cardiac Amyloidosis in the Era of Multimodality Imaging
por: Sunayama, Tsutomu, et al.
Publicado: (2021)

Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases
por: Masumoto, Akiko, et al.
Publicado: (2022)

Assessing fluid volume and determining outcomes of acute heart failure using plasma human atrial natriuretic peptide
por: Suzuki, Yuya, et al.
Publicado: (2023)

Illuminations
por: Benjamin, Walter, 1892-1940
Publicado: (1969)

Illuminations /
por: Benjamin, Walter, 1892-1940
Publicado: (1986)

Diagnosis of isolated cardiac sarcoidosis based on new guidelines
por: Kawai, Hideki, et al.
Publicado: (2020)

Intensive Care Unit Admission for Moderate-to-Severe COVID-19 Patients With Known Cardiovascular Diseases or Their Risk Factors　― Insights From a Nationwide Japanese Cohort Study ―
por: Yoshida, Naofumi, et al.
Publicado: (2021)

Daprodustat for anaemia in patients with heart failure and chronic kidney disease: A randomized controlled study
por: Iso, Takashi, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6eih9fhosgu1i9cr3tavocpg3k